Intralymphatic GAD-Alum (Diamyd®) improves glycemic control in Type 1 diabetes patients carrying HLA DR3-DQ2
Keyword(s):
Keyword(s):
Keyword(s):
2014 ◽
Vol 99
(3)
◽
pp. 800-807
◽
Keyword(s):
2019 ◽
Keyword(s):
2019 ◽
Keyword(s):
2019 ◽
Keyword(s):